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As part of a search for T cell autoantigens in
inflammatory skin diseases, we have demonstrated
proteinase K sensitive, denaturation stable, T cell
stimulatory material with antigenic properties in
aqueous extracts of stratum corneum from normal
human skin. Activity was also demonstrable in extracts
of whole epidermis. A combination of preparative,
analytical, and microbore reversed phase high per-
formance liquid chromatography, chromatofocusing,
and denaturing preparative sodium dodecylsulfate-
polyacrylamide gel electrophoresis indicated limited
structural diversity. Five components were separated,
with Mr values from 5 to 18 kDa and apparent PI
values from 4.5 to 10. Three components were purified
to near homogeneity and showed molecular weights
of 5, 13.5, and 18 kDa. Their potency was shown by
T cells play a key role in the pathogenesis of commoninflammatory skin diseases such as psoriasis and atopicdermatitis (Bos et al, 1983; Lever et al, 1987; VanJoost et al, 1988; Sowden et al, 1991; Ruzicka et al,1997), but the precise mechanisms involved are the
subject of ongoing studies. Psoriasis is widely regarded as an
autoimmune disease (Valdimarsson et al, 1995; Banchereau and
Steinman, 1998), but T cell autoantigens have not yet been
identified in the skin in this (Horrocks et al, 1997) or any other
inflammatory skin disease. The pathogenesis of atopic dermatitis
appears to depend, at least in part, on T helper type 2 (Th2)
responses to common environmental antigens including those of
the house dust mite, Dermatophagoides pteronyssinus (Wierenga et al,
1990; van der Heijden et al, 1991). In addition, independent groups
have demonstrated convincing positive epicutaneous patch test
reactions in subjects with atopic dermatitis but not normal controls,
using aqueous extracts of ‘‘human dander’’ (essentially hair and
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the ability to induce stimulation indices of 20–89 with
peripheral blood mononuclear cells and >500 with T
cell lines. Use of inhibitors indicated that the active
materials were not generated by the in vitro actions of
proteases during extraction. The five partially purified
components induced a time course of peripheral blood
mononuclear cell proliferation compatible with the
effects of antigen rather than superantigen. The 5 kDa
component was rigorously bulk purified to yield a
fraction that induced potent T cell activation but
contained minimal detectable protein, a further
indication of its biologic potency. Normal stratum
corneum thus contains previously undescribed T cell
antigens of high potency but limited structural
diversity. The present data form a basis for determin-
ing their structure, cellular origin, and pathogenic
relevance. J Invest Dermatol 113:355–363, 1999
stratum corneum) as antigen (Uehara and Ofuji ,1976; Young et al,
1985). Part of this ‘‘human dander’’ reactivity may be due to T
cell responses to commensal micro-organisms, as contact sensitivity
to extracts of Pityrosporum species has been demonstrated in atopic
dermatitis patients (Rokugo et al, 1990).
We have recently reported the preliminary biologic characteriza-
tion of previously unrecognized, potent T cell stimulatory material
in aqueous extracts of both autologous and allogeneic normal
human stratum corneum (SC) (Hales and Camp, 1998). Peripheral
blood mononuclear cells (PBMC) of normal volunteers and patients
with psoriasis and atopic dermatitis were found to undergo pro-
nounced proliferative responses to aqueous SC extracts. Inhibition
of these responses by HLA-DR blocking antibody, the ability to
generate SC-specific T cell clones and lines (predominantly CD41),
and the finding that T cell lines and clones specific for other
antigens failed to respond to the SC extracts, indicated that the
active material is antigenic, as opposed to non-specific T cell
stimulant such as cytokine or mitogen (Hales and Camp, 1998).
Determination of the pathogenic importance of these antigens
depends at least in part on their diversity. We now confirm the
polypeptide nature of the active material and demonstrate by
detailed chromatography and electrophoresis that it is not highly
diverse structurally. The results provide a basis for structural
identification and determination of pathogenic relevance.
MATERIALS AND METHODS
Reagents, solvents, media Recombinant interleukin (rIL)-2 and [3H]-
thymidine (2 Ci per mmol) were obtained as described (Hales and Camp,
1998). Standard culture medium (RH10) was RPMI 1640 supplemented
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with 10% human AB serum and 3 mM glutamine but without antibiotics
(Hales and Camp, 1998). Earle’s balanced salts solution (EBSS) was from
Life Technologies (Paisley, U.K.); high performance liquid chromatography
(HPLC) grade solvents from Fisher (Loughborough, U.K.); phenylmethyl-
sulfonyl fluoride (PMSF) from ICN (Thame, U.K.); and trifluoroacetic acid
(TFA), ethylenediaminetetraacetic acid (EDTA), leupeptin, and pepstatin A
from Sigma (Poole, U.K.). Novex MultiMark molecular weight standards
for electrophoresis were from R&D Systems (Abingdon, U.K.).
Sample extraction, protease inhibition, and proteinase K
digestion SC samples were recovered as electric razor shavings (ERS)
and heel scrapings from two male volunteers with normal skin, and were
acetone washed, sterilised by [60Co] irradiation, extracted by shaking in
0.146 M NaCl at 4°C for 48 h, and stored at –80°C as described (Hales
and Camp, 1998). ERS were also subjected to glass-on-glass homogenisation
(90 mg ERS per ml 0.146 M NaCl with or without 10 mM EDTA,
40 µM leupeptin, 1 mM PMSF, and 10 µM pepstatin A) for 5 min at
4°C. Extracts with or without protease inhibitors were microcentrifuged,
filtered (0.45 µM), and 1 ml aliquots subjected immediately to reversed
phase (RP)-HPLC and bioassay of 1.5 ml fractions as described below.
Full thickness normal skin was obtained from patients undergoing breast
reduction surgery, trimmed of subcutaneous fat, and pieces of approximately
4 cm 3 8 cm immersed in distilled, deionised water at 60°C for 1 min.
Epidermis was gently stripped from underlying dermis with forceps and a
scalpel, frozen on CO2 ice, and powdered by CO2 ice-cooled mortar and
pestle. The powder was washed twice in excess acetone, centrifuged, and
the pellet vacuum desiccated. The residue was sterilized by [60Co] (at least
10 kGy), resuspended in PBS (1 g per 20 ml), agitated for 48 h at 4°C,
centrifuged, the supernatant filtered (0.45 µm), and stored at –80°C.
Proteinase K digestions were carried out as previously described
(Beckman et al, 1994). Briefly, ERS extract was purified by RP-HPLC,
and biologically active fractions of intermediate hydrophobicity (see Results)
pooled, assayed for total protein (Micro BCA kit, Pierce and Warriner,
Chester, U.K.), and evaporated. Aliquots (100 µg) were incubated with
10 µg proteinase K (specific activity 20 U per ml; Boehringer Mannheim,
Lewes, U.K.) in 0.05 M NH4 HCO3 and 1 mM CaCl2 (final volume
220 µl) for 2 h at 37°C. Following heat inactivation for 5 min at 65°C, a
further 10 µg proteinase K was added, the incubation continued for 15 h
at 37°C and then frozen at –20°C. Control incubations, which contained
no proteinase K, were carried out in parallel. Subsequently thawed samples
were serially diluted in RH10 and subjected to T cell proliferation assays
with both PBMC alone and an ERS-responsive T cell line with irradiated,
autologous PBMC as APC (see below). Thawed samples were also purified
by RP-HPLC and appropriate fractions evaporated and bioassayed.
HPLC Solvent was delivered by a Waters 626 non-metallic system. RP-
HPLC columns included a 4.6 3 100 mm Brownlee Aquapore RP-300
C8 analytical column, a 10 3 100 mm Brownlee Aquapore Prep-10 C8
preparative column (Applied Biosystems), a 4.6 3 250 mm Atlantis 5µ
C18 300Å analytical column (Phenomenex), and a 2 3 250 mm Jupiter
5µ C18 300Å microbore column (Phenomenex), as described under
Results. Chromatofocusing was carried out on a 7.5 mm 3 75 mm Bio-
Gel DEAE-5-PW anion exchange column eluted at 1 ml per min with a
mixture of three ammonium acetate-containing buffers: buffer A (20 mM
ammonium acetate adjusted to pH 10 with 0.88 specific gravity ammonia),
buffer B (20 mM ammonium acetate adjusted to pH 8 with ammonia),
and buffer C (20 mM ammonium acetate adjusted to pH 4 with trifluo-
roacetic acid). A linear gradient of 100% buffer A to 100% buffer B was
delivered over 10 min, followed by a linear gradient to 90% buffer B/10%
buffer C at 25 min, to 85% buffer B/15% buffer C at 35 min, to 80%
buffer B/20% buffer C at 40 min, and finally to 100% buffer C at 45 min.
This system enables delivery of approximately linear effluent pH gradient
from 10 to 4 over 60 min. Furthermore, the volatility of the solvent
components allows lyophilization of effluent fractions and bioassay of
residues without the need for dialysis. HPLC fractions were collected and
freeze-dried in a centrifugal evaporator. Residues were tested in proliferation
assays with PBMC or T cell lines.
Gel electrophoresis, nitrocellulose immunoblotting, and amino acid
sequencing In preliminary experiments 8 mm 3 8 mm pieces of
nitrocellulose membrane (0.45 µm, pore-sized Hybond-ECL, Amersham,
U.K.) were soaked in an excess of aqueous ERS extract for 60 min at
room temperature. Both undenatured extract and that denatured by heating
at 99°C in 5% vol/vol 2-mercaptoethanol, 10% wt/vol SDS for 5 min
before being allowed to cool for 85 min at room temperature, were used.
The nitrocellulose pieces were then washed successively in an excess of
20% methanol in Earle’s balanced salts solution (EBSS), then 20% ethanol
in EBSS, then finally two washes in EBSS alone. Each wash was continued
for 10 min at room temperature with agitation. The nitrocellulose pieces
were cut into four 4 mm 3 4 mm portions, and each portion placed on
the base of a flat-bottomed microtitre plate well. An ERS-reactive T cell
line (2 3 105 per ml) and irradiated PBMC (2 3 106 per ml) were added
to each well (total volume 0.2 ml RH10 medium) over the nitrocellulose
pieces and incubated for 3 d as in standard proliferation assays. Cultures were
pulsed with [3H]thymidine, cells harvested and thymidine incorporation
determined as described below. Thereafter RP-HPLC-purified fractions
were denatured and subjected to Tris-Tricine-SDS-PAGE (Schagger and
von Jagow, 1987) on 16 cm 31 mm vertical slab gels containing 16%
acrylamide, 0.5% bisacrylamide, and 1.3% glycerol. Separated polypeptides
were electroblotted onto Hybond-ECL nitrocellulose membranes that were
washed as described above, dried, and lanes cut into 10 mm 3 2 mm
strips. The strips were divided and the two halves placed in a microtitre
well with the gel-facing surface upwards, irradiated PBMC (106 per ml)
and an autologous ERS-responsive T cell line (2 3 105 per ml) added,
and proliferation determined in 3-d assays as described below. For amino
acid sequencing, parallel lanes were simultaneously electroblotted from
Tris-Tricine gels onto adjacent nitrocellulose and Fluorotrans 0.2 µm
polyvinylidine difluoride (PVDF) membranes (Flowgen, Lichfield, U.K.).
Typically, electroblotting was performed in buffer containing 48 mM Tris,
39 mM glycine, 10% methanol, and 0.03% SDS, for 2 h at 250 mAmp in
a cold room. PVDF membranes were stained with Coomassie Blue,
destained, washed several times in water, dried, and when possible protein
bands co-migrating with biologic activity on nitrocellulose strips were
identified. These were excised and subjected to N-terminal amino acid
sequencing by Edman degradation in an ABI 476 liquid phase protein
sequencer (Applied Biosystems). PVDF membranes, which were required
for sequencing, could not readily be used in T cell proliferation assays in
place of nitrocellulose as their hydrophobic nature caused the small strips
to float on the surface of culture media.
T cell proliferation assays PBMC (5 3 105 per ml) and ERS-responsive
T cell lines (2 3 105 per ml) were prepared from venous blood of healthy
volunteer JMH, and used in 3- and 5 d proliferation assays respectively
(total volume 0.2 ml) as described previously (Hales and Camp, 1998).
Autologous, irradiated (25 Gy) PBMC (0.5–2 3 106 per ml) were used as
antigen presenting cells (APC) in assays with T cell lines. Cultures were
pulsed with [3H]thymidine (1 µCi) for the last 6 h, cells harvested, counted
by liquid scintillation, and results expressed as counts per min (cpm) or
stimulation indices (SI; cpm in presence of test material 4 cpm from
control incubations).
RESULTS
Biologic activity in ERS extracts is stable to denaturation
and induces T cell proliferation following adsorption to
nitrocellulose Native ERS extract and that denatured by boiling
with 2-mercaptoethanol and SDS were adsorbed onto nitrocellulose
membranes which were thoroughly washed as described under
Materials and Methods. Pieces of membrane were placed in microtitre
wells with an ERS-responsive T cell line and irradiated autologous
PBMC, in standard 3-d proliferation assays. Substantial activation
of the T cell line by adsorbed, native ERS extract was demonstrated
(12,132 cpm, SI 111, mean of quadruplicate assays), and this
increased following denaturation (26,760 cpm, SI 205, mean of
quadruplicate assays).
Purification of SC and epidermal extracts by RP-HPLC
demonstrates biologic activity of intermediate hydro-
phobicity, which is unaffected by protease inhibitors RP-
HPLC of ERS extract was done on a 4.6 3 100 mm Brownlee
Aquapore analytical column eluted with 0.1% aqueous TFA for
5 min at 1 ml per min, followed by a linear gradient to 0.1% TFA
in acetonitrile at 35 min. Assay of fractions for PBMC proliferation
revealed activity in adjacent fractions eluting at approximately 33–
55% acetonitrile (16–22 min) and coinciding with several UV
absorbing peaks. The same profile of biologic activity was seen if
redissolved residues from HPLC fractions were placed in prolifera-
tion assays for a full 5 d, or if PBMC were pulsed with redissolved
residue for 24 h, washed, then re-incubated for a further 4 d
(Fig 1A–C). The latter procedure was adopted in view of the
evidence that SC extracts contain T cell inhibitory material, the
effects of which may be overcome by pulsing cultures with extract
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for 24 h (Hales and Camp, 1998). Typically, total protein in a 1 ml
ERS sample was 600 µg, whereas total protein in a corresponding
16–22minRP-HPLCfractionwas30µg (MicroBCAkit), indicating
approximately 20-fold purification.
When heel SC extract was purified by the same RP-HPLC
system and fractions tested in 5-d PBMC proliferation assays,
biologic activity coinciding with several UV absorbing peaks was
again seen in fractions eluting at about 50% acetonitrile (Fig 1D,
E ). Analysis of an aqueous extract of heat separated, full thickness
epidermis from normal skin in the same RP-HPLC system, also
showed PBMC stimulating material with a similar retention time
(Fig 2).
RP-HPLC (Brownlee analytical column) of ERS extracts
obtained in the presence and absence of protease inhibitors as
described under Materials and Methods, and assay of fractions for
PBMC proliferation, showed the same profiles of biologic activity
(Fig 3), indicating that the T cell stimulatory material in SC
extracts is not generated during extraction by the action of
solubilized proteases. HPLC purification was introduced as the
protease inhibitors interfered with PBMC proliferation if extracts
were assayed directly (data not shown). The broader peaks of
biologic activity in the HPLC of Fig 3 compared with Fig 1 are
due to loading of larger amounts of protein.
RP-HPLC and SDS-PAGE with nitrocellulose T cell immu-
noblotting of ERS extract show 5–18 kDa biologic
activity ERS extract was purified by reversed phase HPLC as
above, residues from biologically active (16–22 min) fractions
were denatured by boiling with 2-mercaptoethanol and SDS, and
subjected to electrophoresis and immunoblotting as described under
Materials and Methods. In preliminary experiments with conventional
SDS-PAGE minigels, T cell immunoblots consistently showed
migration of the major active material to the bottom of the gels
(maximum cpm 52,590-84, 100; SI 177-353; n 5 2; data not
shown), indicating relatively low molecular weight. Tris-Tricine
gels (16 cm) were therefore used subsequently. The 16–22 min
residue following RP-HPLC of 1 ml ERS extract was halved and
subjected to Tris-Tricine SDS-PAGE in parallel lanes. Following
parallel electroblotting onto nitrocellulose and PVDF membranes
as described under Materials and Methods, proliferation assays
incorporating 2 mm nitrocellulose strips, an ERS-responsive T cell
line, and irradiated autologous PBMC revealed biologic activity
within the range of 5–18 kDa (Fig 4B). The major biologically
active peak (Mr value approximately 13 kDa, maximum SI 102)
co-migrated with a prominent Coomassie Blue-stained band on
the PVDF paper (Fig 4A). This band was excised and sequenced,
giving a 19-residue N-terminal sequence (ILE-PRO-GLY-GLY-
LEU-SER-GLU-ALA-LYS-PRO-ALA-THR-PRO-GLU-ILE-
GLN-GLU-ILE-VAL) completely homologous with that of
human epidermal cystatin A (Takeda et al, 1989). This is an 11 kDa,
pI 5 cysteine protease inhibitor that was previously reported to be
identical to cystatin A from liver, spleen, and leukocytes except for
the lack of an N-terminal methionine residue (Takeda et al, 1989),
as found in the present work. Commercially available human
placental cystatin A (Calbiochem, Nottingham, U.K.; N-terminal
sequence MET - ILE - PRO - GLY - GLY - LEU - SER - GLU -
ALA-LYS-PRO-ALA-THR-PRO-GLU-ILE-GLN) was tested
(1, 2, 4, 8, 16, 32 and 84 µg per ml) in proliferation assays
containing an ERS-reactive T cell line and irradiated PBMC. No
activity significantly greater than control RH10 medium alone was
obtained (cpm ,200). It was concluded that epidermal cystatin A
was likely to be a contaminant co-migrating with the major
biologically active peak in Fig 4B. More rigorous sequential HPLC
Figure 1. Biologic activity in ERS and heel SC extracts has discrete
mobility in RP-HPLC. (A, B) UV absorbance profile and biologic
activity in fractions following RP-HPLC of a 300 µl ERS sample.
Evaporated 1 min fractions were redissolved in 300 µl RH10 medium and
PBMC proliferation determined in 5 d assays at 30% (u) and 10% (j)
final concentration. (C) Biologic activity in fractions after RP-HPLC of a
further 300 µl ERS sample. Fraction residues were redissolved in 300 µl
RH10 and incubated for 24 h with PBMC at 75% final concentration.
PBMC were then washed, resuspended in medium, and thymidine
incorporation determined after incubation for a further 4 d. (D, E ) UV
absorbance profile and biologic activity in fractions following RP-HPLC
of a 300 µl heel SC sample. Evaporated 1 min fractions were redissolved
in 300 µl RH10 and PBMC proliferation determined in 5 d assays at 30%
(u) and 10% (j) final concentration. Mean cpm from triplicate or
quadruplicate assays are shown (B, C, E ).
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Figure 2. Extract of whole epidermis also contains biologic activity
of intermediate hydrophobicity on RP-HPLC. UV absorbance profile
(A) and biologic activity in fractions (B) following RP-HPLC of a 1.1 ml
sample. Evaporated 1.5 min fractions were redissolved in 440 µl RH10
medium and PBMC proliferation determined in 5 d assays at 50% final
concentration. Mean cpm from quadruplicate assays are shown.
purifications were therefore undertaken prior to further SDS-PAGE
and T cell immunoblotting.
Bulk purification of ERS extract by successive RP-HPLC,
chromatofocusing, and preparative SDS-PAGE shows
several potent T-cell stimulating components In preliminary
experiments, 5 ml ERS extract was subjected to RP-HPLC on
the 4.6 mm 3 10 mm Brownlee analytical column and biologically
active 16–22 min fractions from repeated runs pooled and evapor-
ated. The residue was re-purified by chromatofocusing on the Bio-
Gel DEAE anion exchange column as described under Materials
and Methods. A biologically active peak eluting early (effluent
pH 10) and two later eluting biologically active peaks (effluent
pH 6 and 4.5 respectively) were individually repurified by RP-
HPLC on a Phenomenex 4.6 3 250 mm column using shallow
acetonitrile gradients. UV absorbing peaks eluting at 35–40%
acetonitrile were collected and found to induce potent activation
of an ERS-reactive T cell line in the presence of autologous,
irradiated PBMC (SI values .200; data not shown). Finally, the
three components were subjected to denaturing Tris-Tricine SDS-
PAGE and nitrocellulose T cell immunoblotting, as described
above. The components with apparent isoelectric points of 10, 6,
and 4.5 showed Mr values of 5, 13.5, and 18 kDa respectively, and
their biologic potency was indicated by SI values of 94–532 (Fig
5A–C). Following these purifications, insufficient material was left
for amino acid sequencing.
We therefore elected to bulk purify the pI 10, 5 kDa component
that gave the SI value of .500 following T cell immunoblotting
(Fig 5A) and appeared to be the most potent component in other
experiments (see Fig 10 below). Initial bulk RP-HPLC purification
Figure 3. Protease inhibitors present during ERS extraction do not
affect the level of PBMC activation. Supernatants (1 ml) obtained in
the absence (A) and presence (B) of protease inhibitors were subjected to
RP-HPLC. Evaporated 1.5 min fractions were redissolved in 320 µl RH10
medium and PBMC proliferation determined in 5 d assays at 8% final
concentration. Mean cpm from duplicate assays are shown.
Figure 4. Tris-Tricine SDS-PAGE of RP-HPLC-purified ERS
extract. Following HPLC of 1 ml ERS extract, the residue from a 16–
22 min fraction was denatured, halved, and subjected to SDS-PAGE in
separate lanes. One lane was electroblotted onto a PVDF membrane and
stained with Coomassie Blue (A). The major band, migrating at Mr
approximately 13 kDa, was excised and sequenced. The second lane was
electroblotted onto a nitrocellulose membrane, 2 mm strips were cut and
assayed for stimulatory activity (B).Migration of molecular weight markers
(Da) is shown at the top of the figure.
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Figure 5. Tris-Tricine SDS-PAGE and nitrocellulose T cell
immunoblotting of three ERS components. The components were
purified initially by two RP-HPLC steps and chromatofocusing (apparent pI
values approximately 10, 6, and 4.5), and show Mr values of approximately 5
(A), 13.5 (B), and 18 (C ) kDa respectively. SI values refer to the most
active fraction in each profile. Migration of molecular weight markers
(kDa) is shown at the top of the figure.
of ERS extract was carried out on the 10 mm 3 100 mm Brownlee
Prep-10 column eluted with 0.1% TFA in water at 3 ml per min.
Three 3.5 ml aliquots of ERS extract were injected successively
prior to initiation of a linear solvent gradient to 0.1% TFA in
acetonitrile over 30 min. Similar UV absorbance profiles to that
shown in Fig 1A were obtained (data not shown) and a group of
fractions containing biologic activity, equivalent to those shown in
Fig 1B, were collected, pooled, and evaporated. A total of 65 ml
ERS extract was subjected to this preparative RP-HPLC system,
the evaporated residue redissolved in 3 ml 20 mM ammonium
acetate adjusted to pH 10 with ammonia, filtered (0.45 µm) and
immediately subjected to a single chromatofocusing run on the
Bio-Gel anion exchange column as described under Materials and
Methods. Assay of a portion of each evaporated 1.5 ml fraction for
activation of an ERS-responsive T cell line in the presence of
autologous irradiated PBMC as APC, showed five sets of biologic-
ally active fractions (peaks 1–5 in Fig 6). Separate experiments
showed that the biologic profiles obtained with autologous and
allogeneic ERS extract were similar (data not shown). The residue
from the fraction eluting at 20 min, immediately after peak 2 (arrow,
Fig 6B) was assayed after serial dilution, which unmasked potent
Figure 6. Chromatofocusing of RP-HPLC-purified ERS extract
shows five groups of biologically active fractions. (A) UV absorbance
profile and pH of effluent fractions. (B) One-tenth of each 1.5 ml fraction
was evaporated, residues redissolved in 320 µl RH10 medium and tested
for stimulation of an ERS-responsive T cell line in the presence of
irradiated PBMC, at 50% final dilution. Each column shows the mean of
triplicate assays. Five sets of biologically active fractions, designated 1, 2,
3, 4, and 5, are shown. Inset: Proliferation of the ERS line in response to
the residue from the fraction eluting at 20 min (vertical arrow). The
residue was redissolved in 350 µl RH10 and assayed in triplicate at the
dilutions indicated.
T cell activation at 80-fold dilution (Fig 6B, inset). The steep
nature of the dose–response curve generated by this fraction, with
near background proliferation at 400-fold dilution but maximal
stimulation following a single further dilution to 80-fold, illustrates
the care required to overcome inhibitory activity in these samples,
as was found previously when assaying unpurified material (Hales
and Camp, 1998). In contrast, serial dilution and assay of the
residue in the 47 min fraction eluting immediately after peak 4
(Fig 6B) did not unmask any T cell stimulation (data not shown).
Peak 1 (Fig 6B) was repurified on the Phenomenex analytical
RP-HPLC column eluted at 1 ml per min with 0.1% TFA in
water for 5 min, followed by a linear gradient to 30% acetonitrile
at 65 min, then to 60% acetonitrile at 95 min. The UV absorbance
profile and biologic activity in collected, evaporated fractions (tested
with an ERS-responsive T cell line and autologous, irradiated
PBMC as APC) is shown in Fig 7. Substantial T cell stimulating
activity was seen in association with minor UV absorbing peaks at
70 min. The remaining residue from the single, major biologically
active peak was repurified by microbore RP-HPLC on a Pheno-
menex 2 3 250 mm column. Elution was at 0.2 ml per min with
0.1% TFA in water for 5 min, followed by a linear gradient to
30% acetonitrile at 80 min, then to 50% acetonitrile at 120 min.
A group of three UV absorbing peaks eluted close together at
85 min, and substantial T cell stimulatory activity was associated
with the tail of the UV absorbing peaks (Fig 8). The residue from
the single biologically active fraction was finally repurified on the
microbore RP-HPLC column eluted at 0.2 ml per min with 0.1%
TFA in water for 5 min, followed by an extremely shallow linear
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Figure 7. Analytical RP-HPLC of the residue from peak 1, Fig 6B.
(A) UV absorbance profile. (B) Biologic activity in fractions. HPLC
conditions are described under Results. One-eighth of each fraction was
evaporated, redissolved in 320 µl RH10, and tested at 50% final
concentration for stimulation of an ERS-responsive T cell line in the
presence of irradiated PBMC. Mean results of triplicate assays are shown.
Figure 8. Microbore RP-HPLC of the residue from the main
biologically active fraction in Fig 7B. (A) UV absorbance profile. (B)
Biologic activity in fractions. HPLC conditions are described under Results.
One-sixth of each fraction was evaporated, redissolved in 320 µl RH10,
and tested at 50% final concentration for stimulation of an ERS-responsive
T cell line in the presence of irradiated PBMC. Mean results of triplicate
assays are shown.
Figure 9. Microbore RP-HPLC of the residue from the biologically
active fraction in Fig 8. (A) UV absorbance profile. (B) Biologic activity
in fractions. HPLC conditions are described under Results. One-tenth of
each fraction was evaporated, redissolved in 320 µl RH10, and tested at
50% final concentration for stimulation of an ERS-responsive T cell line
in the presence of irradiated PBMC. Mean results of triplicate assays
are shown.
gradient to 22% acetonitrile at 60 min, then to 40% acetonitrile at
7 h. Major T cell stimulatory activity eluted at 145–150 min, but
was unexpectedly associated with a tail of minor UV absorbing
material containing minimal detectable protein (Fig 9) that was
insufficient for conventional amino acid sequencing.
Five partially-purified, SC-derived components elicit
maximal PBMC proliferation at 5–7 d A further aliquot of
ERS extract was purified by Prep-10 RP-HPLC as described
above. Appropriate biologically active fractions were pooled, evap-
orated, and repurified by chromatofocusing on the Bio-Gel anion
exchange column as above. UV absorbance profiles and biologic
activity were very similar to those in Fig 6 (data not shown). The
biologically active fractions equivalent to peaks 1–5 in Fig 6B
were evaporated and individually tested for their ability to stimulate
proliferation of PBMC (5 3 105 per ml) in 3-, 5-, and 7-d
assays. Appropriate final dilutions of the individual residues were
determined in preliminary experiments. Material from each peak
stimulated PBMC proliferation, the maximal responses occurring
at days 5 or 7, with relatively little activity at day 3. The material
in peak 1 appeared to be the most potent (Fig 10).
T cell stimulating activity in ERS extract is proteinase K
sensitive T cell proliferation elicited by RP-HPLC (Brownlee
Prep-10)-purified ERS extract was largely abolished by incubation
with proteinase K, following assays with both PBMC (Fig 11A)
and with an ERS-responsive T cell line and autologous, irradiated
PBMC as APC (Fig 11B). The samples that contained the added
proteinase K caused non-specific inhibition of PBMC proliferation
when present in amounts greater than found in the dilutions
represented in Fig 11A and B. This was confirmed by separate
experiments in which a wide range of concentrations of proteinase
K were added to ERS samples immediately before analysis in
PBMC proliferation assays (data not shown). Therefore, to confirm
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Figure 10. Time dependence of the proliferative responses of
unprimed PBMC to residues from fractions equivalent to peaks 1–
5 in Fig 6B. Appropriate sample dilutions were established in preliminary
experiments, and thymidine incorporation determined after 3, 5, and 7 d.
The figures at the top of each column represent SI values. *82,108 cpm.
that abolition of biologic activity by proteinase K was not due to
a non-specific inhibitory effect of the protease in the T cell
proliferation assays, both control samples and those incubated with
proteinase K were re-purified by RP-HPLC prior to bioassay of
appropriate fractions. Biologic activity was seen in HPLC fractions
of samples from control incubations (Fig 11C, D) but was again
barely detectable in samples incubated with proteinase K (Fig
11E, F).
DISCUSSION
Previously unrecognised T cell stimulatory materials with similar
retention times on RP-HPLC have been recovered from both
ERS and heel SC and from whole epidermal samples from normal
skin. Although recent work, in which T cell clones generated in
response to heel SC extracts were shown to respond to ERS
extract, suggests that the antigenic material from the two sources
is at least in part similar (Hales and Camp, 1998), detailed
chromatographic and electrophoretic characterization has to date
only been carried out with ERS samples. Proteinase K digestion
abolished the activity, confirming its polypeptide nature, but the
activity was enhanced by denaturation. The latter finding is
consistent with the presence of polypeptide antigen and is likely
to be the result of enhanced antigen processing, which has been
shown in several studies to be dependent on disulfide reduction
(reviewed in Watts, 1997). The stability of the biologic activity to
denaturation also indicated the possibility of including denaturing
SDS-PAGE and nitrocellulose T cell immunoblotting (Lamb et al,
1988) in the purification strategy, and this was subsequently used
to demonstrate the limited molecular weight range (5–18 kDa) of
the active materials.
SDS-PAGE, T cell immunoblotting, and amino acid sequencing
of partly purified ERS extract showed co-migration of epidermal
cystatin A (Takeda et al, 1989) with the major T cell stimulating
activity. Authentic cystatin A, however, did not activate an ERS-
responsive T cell line, suggesting that this polypeptide was a
contaminant. The ability to obtain an N-terminal sequence after
purification of less than 1 ml ERS extract points to the abundance
of this cysteine protease inhibitor in human epidermis. Although
epidermal cystatin A appears not to be autoantigenic, its abundance
suggests that it may play an important role in epidermal biology,
e.g., in inhibiting IL-1 converting enzyme (Miller et al, 1993) or
the cysteine protease activity of the house dust mite antigen Der p 1
(Hewitt et al, 1995; Schulz et al, 1995, 1997, 1998). Preliminary
studies have shown that cystatin A does not inhibit caspase 3-like
activity involved in apoptosis (S Chow and J Hales, unpublished).
Normal serum antibodies that bind to components in aqueous
extracts of human SC and in SC of frozen sections of human skin,
have been known for many years (Binder et al, 1980; Dabski et al,
1985), but the epitopes involved and their pathogenic relevance
are unclear. Although serum antibodies against keratin intermediate
filaments have been described (Hintner et al, 1985), evidence
indicates that SC antibodies are not directed against keratin inter-
mediate filaments (Qutaishat et al, 1990). In addition, the similarity
between the SC antigens recognized by serum antibodies and by
T cells is not known.
The time course of PBMC proliferation in response to five
partly purified SC components showed maximal stimulation at 5–
7 d with relatively low or minimal responses at 3 d. These properties
suggest the presence of antigen as opposed to superantigen, which
is capable of inducing potent proliferation of large populations of
PBMC in short-term assays (Choi et al, 1989; Kotzin et al, 1993).
Previous work has shown that ERS and heel SC extracts were not
capable of activating a polyclonal PPD-reactive T cell line (Hales
and Camp, 1998). In addition, the activity in ERS extract is
enhanced by denaturation and one of the most potent components
has a molecular weight of only 5 kDa. Although these findings
provide additional circumstantial evidence for the presence of
antigen, further work preferably with homogeneously pure material
will be required to exclude superantigenic activity.
The cellular source and pathogenic relevance of the active
materials have not yet been established, and the possibility that at
least some are derived from commensal skin microbes cannot be
excluded. This possibility does not diminish the potential pathogenic
importance of the activity, as responses to microflora have been
strongly implicated in skin diseases including psoriasis (Valdimarsson
et al, 1995) and atopic dermatitis (Rokugo et al, 1990; McFadden
et al, 1993). The ability of extracts of whole epidermis to induce
T cell responses (Fig 2), however, suggests the viable epidermis as
a source of at least part of the active materials. Whatever the source,
the most promising disease association appears to be with atopic
dermatitis, in which positive epicutaneous patch tests to ‘‘human
dander’’ have been clearly demonstrated (Simon, 1949; Uehara and
Ofuji, 1969, 1976; Young et al, 1985). Further in vitro and
in vivo studies with pure components are required, the limited
chromatographic and electrophoretic diversity of the active mat-
erials, as shown in this study, indicating that this should be feasible.
Structural identification will be essential, but T cells may respond
to concentrations of peptide/MHC complexes that are lower than
can be detected by conventional biochemical means (Shastri, 1996;
Watts, 1997). This is exemplified by our recovery of substantial T
cell stimulating activity but minimal detectable protein in a micro-
bore RP-HPLC fraction following rigorous bulk purification of
the 5 kDa component (Fig 9), and by the fact that, to our
knowledge, there has been only one previous report of the successful
identification of a CD41 T cell antigen following conventional
biochemical purification of a human tissue extract (Van Noort et al,
1995). In the latter work, homogeneously pure material was
apparently obtained from multiple sclerosis brain tissue following
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a single RP-HPLC step. The material induced SI of ,8 with
primed T cell lines, and a sequence for αB-crystallin was obtained
following trypsinization, indicating the presence of relatively abund-
ant polypeptide of modest antigenic potency.
Initially, our finding of potent T cell stimulation but minimal
detectable protein in the same microbore RP-HPLC fraction (Fig
9) led us to suspect the presence of CD1-associated, non-peptide,
lipoglycan-like antigen, perhaps microbially derived (Beckman et al,
1994; Sieling et al, 1995; Sugita et al, 1996). This was disproved,
however, by the effects of proteinase K, the inhibitory effects of
HLA-DR monoclonal antibody, and the fact that ERS and heel
SC responsive T cell lines are 88–93% CD41 (Hales and Camp,
1998), as CD1-associated glycolipids are recognized by CD4–
human T cells (Porcelli et al, 1992; Gong et al, 1998).
The relevance of antigens that are present in normal SC and
activate the PBMC not only of psoriasis but atopic dermatitis
patients, but also of normal donors (Hales and Camp, 1998), may
be questioned. It should be noted, however, that the previous
assays showing the response of atopic, psoriatic, and normal PBMC
to SC extract, were not intended to be precisely quantitative, and
differences between the subject groups may have been missed.
Precise differences between the groups may only be demonstrable
once individual, homogeneously pure components are tested.
Furthermore, the status of SC antigens may be reflected in findings
with several well-recognized antigens, including those in house
dust mite species, which are reported in some studies to induce
similar in vitro proliferative responses with peripheral blood T cells
from both normal and atopic subjects (Cavaillon et al, 1988; van
Neerven et al, 1996), but only to give positive skin tests in the
atopics. This apparent anomaly may be explained in a number of
ways, including the potency of antigen presentation by peripheral
blood dendritic cells used in assays incorporating PBMC as APC
(Banchereau and Steinman, 1998), and the fact that antigen-specific
T cells in patients with active psoriasis and atopic dermatitis may
have migrated to the skin (van der Heijden et al, 1991), leading to
their relative depletion in peripheral blood. In addition, in vivo T
cell responses to antigen in atopics may be enhanced greatly by the
presence of antigen-specific IgE (Mudde et al, 1990; van der
Heijden et al, 1993), which is usually not present in in vitro assays
incorporating human AB serum, as in the present experiments.
Finally, SC antigens in the skin of normal subjects may not be
presented efficiently by Langerhans cells. Thus, immature Langer-
hans cells in the normal epidermis, although well equipped to
capture and process antigen, are found in many experiments only
to be weak T cell stimulators (Banchereau and Steinman, 1998).
In contrast, pathologic states characterized by inflammation and
release of cytokines including IL-4 and granulocyte-macrophage
colony-stimulating factor, may lead to Langerhans cell maturation
into cells that express increased levels of major histocompatibility
complex proteins and accessory molecules, and are potent T cell
stimulators (Banchereau and Steinman, 1998). This concept is
supported by work showing that fresh epidermal cell suspensions
from normal human skin are poor at alloantigen presentation,
whereas epidermal cell suspensions prepared from psoriatic lesions
demonstrate potent alloantigen presenting capacity (Baadsgaard
et al, 1989).
Recently, Valenta et al. (1998) have reported the presence in
Figure 11. Abolition of T cell proliferative responses to RP-HPLC-
purified ERS extract following digestion with proteinase K. ERS
samples were purified by preparative RP-HPLC (Brownlee Prep-10
column) and a fraction of intermediate hydrophobicity, representing the
biologic activity illustrated in Fig 1B, used for digestions and control
incubations as described in Materials and Methods. (A) Proliferation of
unprimed PBMC and (B) proliferation of an ERS-reactive T cell line in
the presence of irradiated, autologous PBMC as APC, in response to
samples from control incubations (u) and those containing proteinase K
(s). (C, E) UV absorbance profiles and (D, F) biologic activity in fractions
following RP-HPLC of control incubations (C, D) and those containing
proteinase K (E, F ). RP-HPLC was done on a 4.6 3 100 mm Brownlee
column eluted as described in the second paragraph of Results. The
proteinase K peak, shown in (E ), eluted about 1 min later than the main
ERS-derived peak seen with samples from control incubations (C).
Fractions (1 min) were evaporated, redissolved in 320 µl RH10 medium,
and assayed at 50% final concentration for proliferative responses of an
ERS-reactive T cell line in the presence of autologous, irradiated PBMC.
Mean results of triplicate bioassays are shown.
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skin and several other tissues of an autoallergen, Hom s 1, recognized
by serum IgE from atopic dermatitis patients. The relationship
between Hom s 1 and the T cell antigens defined in this work, is
unclear. Hom s 1 reacts with IgE and there is no available evidence
to suggest that it stimulates T cells. Furthermore, its apparent
molecular weight (55 kDa) is much greater than that of the major
T cell antigens reported here (5–18 kDa; see Figs 4 and 5).
Structural identification of the T cell stimulating components in
human SC and epidermis should open important avenues in
research into the pathogenesis of T cell mediated skin diseases and
may reveal targets for immunotherapy. Whether HPLC purification
of a very large bulk of SC extract will generate sufficient amounts
of pure polypeptide to allow amino acid sequencing by tandem
mass spectrometry, which is more sensitive than conventional
sequencing (Chicz et al, 1992, 1993; Pappin et al, 1996), is uncertain.
An expression cloning approach, which has been used for the
identification of a range of T cell peptide antigens (Shastri, 1996),
may be more successful and is currently being pursued.
We are indebted to Dr. Kathryn Lilley, Protein and Nucleic Acid Chemistry
Laboratory, University of Leicester, for carrying out amino acid sequencing. This
work was supported by grants from Novartis Pharmaceuticals UK and the Leicester
Dermatology Research Foundation.
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